Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease - Voss_2018_Alzheimers.Dement.(N.Y)_4_173 |
| Author(s) : Voss T , Li J , Cummings J , Farlow M , Assaid C , Froman S , Leibensperger H , Snow-Adami L , McMahon KB , Egan M , Michelson D |
| Ref : Alzheimers Dement (N Y) , 4 :173 , 2018 |
| Abstract : Voss_2018_Alzheimers.Dement.(N.Y)_4_173 |
| ESTHER : Voss_2018_Alzheimers.Dement.(N.Y)_4_173 |
| PubMedSearch : Voss_2018_Alzheimers.Dement.(N.Y)_4_173 |
| PubMedID: 29955661 |
| Title : Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors - Ferris_2013_Clin.Interv.Aging_8_1007 |
| Author(s) : Ferris SH , Farlow M |
| Ref : Clin Interv Aging , 8 :1007 , 2013 |
| Abstract : Ferris_2013_Clin.Interv.Aging_8_1007 |
| ESTHER : Ferris_2013_Clin.Interv.Aging_8_1007 |
| PubMedSearch : Ferris_2013_Clin.Interv.Aging_8_1007 |
| PubMedID: 23946647 |
| Title : Evaluating the cognitive effects of donepezil 23 mg\/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response - Sabbagh_2013_BMC.Geriatr_13_56 |
| Author(s) : Sabbagh M , Cummings J , Christensen D , Doody R , Farlow M , Liu L , Mackell J , Fain R |
| Ref : BMC Geriatr , 13 :56 , 2013 |
| Abstract : Sabbagh_2013_BMC.Geriatr_13_56 |
| ESTHER : Sabbagh_2013_BMC.Geriatr_13_56 |
| PubMedSearch : Sabbagh_2013_BMC.Geriatr_13_56 |
| PubMedID: 23742728 |
| Title : Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review - Kurz_2009_Int.J.Clin.Pract_63_799 |
| Author(s) : Kurz A , Farlow M , Lefevre G |
| Ref : Int J Clin Pract , 63 :799 , 2009 |
| Abstract : Kurz_2009_Int.J.Clin.Pract_63_799 |
| ESTHER : Kurz_2009_Int.J.Clin.Pract_63_799 |
| PubMedSearch : Kurz_2009_Int.J.Clin.Pract_63_799 |
| PubMedID: 19392927 |
| Title : IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease - Winblad_2007_Neurology_69_S14 |
| Author(s) : Winblad B , Grossberg G , Frolich L , Farlow M , Zechner S , Nagel J , Lane R |
| Ref : Neurology , 69 :S14 , 2007 |
| Abstract : Winblad_2007_Neurology_69_S14 |
| ESTHER : Winblad_2007_Neurology_69_S14 |
| PubMedSearch : Winblad_2007_Neurology_69_S14 |
| PubMedID: 17646619 |
| Title : Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study - Edwards_2007_Dement.Geriatr.Cogn.Disord_23_401 |
| Author(s) : Edwards K , Royall D , Hershey L , Lichter D , Hake A , Farlow M , Pasquier F , Johnson S |
| Ref : Dementia & Geriatric Cognitive Disorders , 23 :401 , 2007 |
| Abstract : Edwards_2007_Dement.Geriatr.Cogn.Disord_23_401 |
| ESTHER : Edwards_2007_Dement.Geriatr.Cogn.Disord_23_401 |
| PubMedSearch : Edwards_2007_Dement.Geriatr.Cogn.Disord_23_401 |
| PubMedID: 17409748 |
| Title : Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 12-week interim analysis - Edwards_2004_Dement.Geriatr.Cogn.Disord_17 Suppl 1_40 |
| Author(s) : Edwards KR , Hershey L , Wray L , Bednarczyk EM , Lichter D , Farlow M , Johnson S |
| Ref : Dementia & Geriatric Cognitive Disorders , 17 Suppl 1 :40 , 2004 |
| Abstract : Edwards_2004_Dement.Geriatr.Cogn.Disord_17 Suppl 1_40 |
| ESTHER : Edwards_2004_Dement.Geriatr.Cogn.Disord_17 Suppl 1_40 |
| PubMedSearch : Edwards_2004_Dement.Geriatr.Cogn.Disord_17 Suppl 1_40 |
| PubMedID: 14676468 |
| Title : Disease stage in Alzheimer disease and treatment effects of rivastigmine - Kurz_2004_Alzheimer.Dis.Assoc.Disord_18_123 |
| Author(s) : Kurz A , Farlow M , Quarg P , Spiegel R |
| Ref : Alzheimer Disease & Associated Disorders , 18 :123 , 2004 |
| Abstract : Kurz_2004_Alzheimer.Dis.Assoc.Disord_18_123 |
| ESTHER : Kurz_2004_Alzheimer.Dis.Assoc.Disord_18_123 |
| PubMedSearch : Kurz_2004_Alzheimer.Dis.Assoc.Disord_18_123 |
| PubMedID: 15494617 |
| Title : Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial - Farlow_2003_Arch.Neurol_60_843 |
| Author(s) : Farlow M , Potkin S , Koumaras B , Veach J , Mirski D |
| Ref : Archives of Neurology , 60 :843 , 2003 |
| Abstract : Farlow_2003_Arch.Neurol_60_843 |
| ESTHER : Farlow_2003_Arch.Neurol_60_843 |
| PubMedSearch : Farlow_2003_Arch.Neurol_60_843 |
| PubMedID: 12810489 |
| Title : A clinical overview of cholinesterase inhibitors in Alzheimer's disease - Farlow_2002_Int.Psychogeriatr_14_93 |
| Author(s) : Farlow M |
| Ref : Int Psychogeriatr , 14 :93 , 2002 |
| Abstract : Farlow_2002_Int.Psychogeriatr_14_93 |
| ESTHER : Farlow_2002_Int.Psychogeriatr_14_93 |
| PubMedSearch : Farlow_2002_Int.Psychogeriatr_14_93 |
| PubMedID: 12636182 |
| Title : Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease - Doody_2001_Dement.Geriatr.Cogn.Disord_12_295 |
| Author(s) : Doody RS , Dunn JK , Clark CM , Farlow M , Foster NL , Liao T , Gonzales N , Lai E , Massman P |
| Ref : Dementia & Geriatric Cognitive Disorders , 12 :295 , 2001 |
| Abstract : Doody_2001_Dement.Geriatr.Cogn.Disord_12_295 |
| ESTHER : Doody_2001_Dement.Geriatr.Cogn.Disord_12_295 |
| PubMedSearch : Doody_2001_Dement.Geriatr.Cogn.Disord_12_295 |
| PubMedID: 11351141 |
| Title : A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease - Farlow_2000_Eur.Neurol_44_236 |
| Author(s) : Farlow M , Anand R , Messina J, Jr. , Hartman R , Veach J |
| Ref : Eur Neurol , 44 :236 , 2000 |
| Abstract : Farlow_2000_Eur.Neurol_44_236 |
| ESTHER : Farlow_2000_Eur.Neurol_44_236 |
| PubMedSearch : Farlow_2000_Eur.Neurol_44_236 |
| PubMedID: 11096224 |
| Title : Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration - Qizilbash_1998_Jama_280_1777 |
| Author(s) : Qizilbash N , Whitehead A , Higgins J , Wilcock G , Schneider L , Farlow M |
| Ref : Jama , 280 :1777 , 1998 |
| Abstract : Qizilbash_1998_Jama_280_1777 |
| ESTHER : Qizilbash_1998_Jama_280_1777 |
| PubMedSearch : Qizilbash_1998_Jama_280_1777 |
| PubMedID: 9842955 |
| Title : Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease - Schneider_1997_Ann.N.Y.Acad.Sci_826_317 |
| Author(s) : Schneider LS , Farlow M |
| Ref : Annals of the New York Academy of Sciences , 826 :317 , 1997 |
| Abstract : Schneider_1997_Ann.N.Y.Acad.Sci_826_317 |
| ESTHER : Schneider_1997_Ann.N.Y.Acad.Sci_826_317 |
| PubMedSearch : Schneider_1997_Ann.N.Y.Acad.Sci_826_317 |
| PubMedID: 9329702 |
| Title : Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease - Poirier_1995_Proc.Natl.Acad.Sci.U.S.A_92_12260 |
| Author(s) : Poirier J , Delisle MC , Quirion R , Aubert I , Farlow M , Lahiri D , Hui S , Bertrand P , Nalbantoglu J , Gilfix BM , Gauthier S , et al. |
| Ref : Proceedings of the National Academy of Sciences of the United States of America , 92 :12260 , 1995 |
| Abstract : Poirier_1995_Proc.Natl.Acad.Sci.U.S.A_92_12260 |
| ESTHER : Poirier_1995_Proc.Natl.Acad.Sci.U.S.A_92_12260 |
| PubMedSearch : Poirier_1995_Proc.Natl.Acad.Sci.U.S.A_92_12260 |
| PubMedID: 8618881 |
| Title : A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group - Farlow_1992_JAMA_268_2523 |
| Author(s) : Farlow M , Gracon SI , Hershey LA , Lewis KW , Sadowsky CH , Dolan-Ureno J |
| Ref : Jama , 268 :2523 , 1992 |
| Abstract : Farlow_1992_JAMA_268_2523 |
| ESTHER : Farlow_1992_JAMA_268_2523 |
| PubMedSearch : Farlow_1992_JAMA_268_2523 |
| PubMedID: 1404819 |